Jeff Baglio concentrates in representation of both mature and emerging technology and life sciences companies in all facets of their business; mergers and acquisitions; venture capital; and public securities offerings.

Recent Matters

• Representation of Invitrogen Corporation in its $6.7 billion acquisition of Applera Corporation.
• Representation of QUALCOMM Incorporated in its acquisition of Firethorn, LLC.
• Representation of MedVantx, Inc. in the completion of its Series B financing.
• Representation of Pfizer, Inc. in the structure and establishment of The Pfizer Incubator.
• Representation of Invitrogen Corporation in its sale of BioReliance to Avista Capital (a cross border transaction in the United Kingdom).
• Representation of Vivendi Games in multiple development studio acquisitions, including Studio Ch’in in China.
• Representation of Yulex Corporation in its Series C financing.
• Representation of Goldman Sachs in follow-on offering by Charlotte Russe.
• Representation of Invitrogen Corporation in its $800 million exchange offer of convertible notes.
• Representation of a public client in connection with a joint venture dissolution.

Honors and Awards

• Daily Journal Names DLA Piper Partner Baglio One of California's 20 Under 40
• DLA Piper partner Jeff Baglio is one of San Diego's 40 Under 40 says San Diego Metropolitan magazine

許可

• California

專業資格

• California and San Diego County Bar Associations
• Board of Directors and Member of Executive Committee, CONNECT

職員資訊

• Law Clerk to Hon. Rudi M. Brewster, US District Court, Southern District of California (1993-1994)

公民與慈善

• Director and General Counsel, 2008 U.S. Open Committee
• Board of Directors and Officer, the Century Club of San Diego